EGFR Exon 20–Positive NSCLC: Future Directions in Care

Video

Before closing out her discussion on novel therapy for EGFR exon 20–positive NSCLC, Zofia Piotrowska, MD, shares her hopes for future developments in care.

Case: A 59-Year-Old Female with Lung Cancer

Initial presentation

  • BC is a 59 y/o Asian female who presents to her physician complaining of shortness of breath, fatigue, and persistent right- sided neck pain.
    • BC believes she is experiencing neck pain because of her new sleeping pillow.
    • Since her last examination 6 months ago, BC has lost close to 10 lbs. BC has not changed her eating habits or style.
    • PMH: Hypercholesterolemia (controlled)
    • SMH: no history of smoking; drinks socially
    • FH: she lives with her partner and 2 dogs; mother passed away from ovarian cancer 3 years ago.
    • PE: LLL auscultation reveals decreased breath sounds visible bruising

Clinical workup

  • Current Labs:
    • CBC panel: Normal
    • Liver function/Renal function: Normal
  • CT Chest: LLL primary, mediastinal LNs; bone metastases
  • Diagnosis: Stage IV adenocarcinoma
  • MRI brain is negative for brain metastases
  • CT scan of abdomen and pelvis shows additional bone metastases
  • Weight: 120 lbs (54.5 kg)
  • Biopsy of mediastinal lymph nodes shows stage 4 lung adenocarcinoma
  • PD-L1 55%

Treatment

  • NGS has been ordered and the results are pending.
  • Patient initiated on a chemotherapy doublet.
Related Videos
The Oncology Brothers with Joshua K. Sabari, MD, presenting slides
The Oncology Brothers with Joshua K. Sabari, MD, presenting slides
The Oncology Brothers with Joshua K. Sabari, MD, presenting slides
The Oncology Brothers with Joshua K. Sabari, MD, presenting slides
The Oncology Brothers with Joshua K. Sabari, MD, presenting slides
Related Content